Horenshtein Hadar Mirit 4
4 · Silexion Therapeutics Corp · Filed Jun 8, 2026
Research Summary
AI-generated summary of this filing
Silexion (SLXN) CFO Mirit Horenshtein Receives 7,500-Share Award
What Happened
Mirit Horenshtein, CFO and Secretary of Silexion Therapeutics Corp (SLXN), was granted 7,500 fully vested restricted share units (RSUs) on June 4, 2026; the RSUs were immediately settled for 7,500 ordinary shares. The Form 4 reports the acquisition price as $0.00, reflecting that these were awards settled into shares rather than a cash purchase.
Key Details
- Transaction date: 2026-06-04 (reported on Form 4 filed 2026-06-08).
- Transaction type/code: Award/Grant (A) — 7,500 shares acquired at $0.00 (RSU settlement).
- Shares owned after transaction: 12,515 ordinary shares (5,015 prior to the grant after a 1-for-10 reverse split, plus 7,500 from this grant).
- Approval/authority: Grant approved by the issuer’s board of directors (per footnote).
- Timeliness: Form 4 filed within the SEC two-business-day window (not late).
Context
- These were RSUs that vested and were immediately converted into shares (not an option exercise or open-market purchase). No cash was paid by the insider for these shares.
- Awards like this are typically compensation for service; they do not, by themselves, indicate a buy or sell signal.
Insider Transaction Report
Form 4
Horenshtein Hadar Mirit
CFO and Secretary
Transactions
- Award
Ordinary Shares
[F1][F2]2026-06-04+7,500→ 12,515 total
Footnotes (2)
- [F1]The number of ordinary shares, par value $0.135 per share ("ordinary shares"), reported in this Form 4 reflects an adjustment relative to the last Form 4 filed by the Reporting Person on February 23, 2026 due to the 1-for-10 reverse share split effected by the Issuer on May 28, 2026 (which caused the 50,146 ordinary shares, par value $0.0135, beneficially owned by the Reporting Person as reported in that Form 4 to become 5,015 ordinary shares, par value $0.135, prior to the grant reported in this Form 4).
- [F2]The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of fully vested restricted share units (RSUs), which were immediately settled for underlying ordinary shares, in respect of the Reporting Person's service as an officer of the Issuer. The grant was approved by the Issuer's board of directors.
Signature
/s/ Mirit Horenshtein Hadar|2026-06-08